White House pulls nomination of Heidi Overton to lead FDA
The White House withdrew the nomination of Heidi Overton to lead the Food and Drug Administration (FDA) amid opposition from Senate Republicans, it confirmed to The Hill. Overton was set to face a key vote Wednesday in the Senate health committee, where Republicans hold only a one-vote majority — meaning losing one member would be...
The White House has decided to withdraw the nomination of Heidi Overton to head the Food and Drug Administration (FDA), citing insufficient congressional backing, according to Axios. This move comes as the Trump administration seeks a new candidate for the role, as HHS Secretary Robert F. Kennedy Jr. aligns with his Make America Healthy Again agenda.
Overton, a physician and deputy director of the White House Domestic Policy Council, had been nominated by President Trump in August but faced opposition from both Democrats and some Republican senators. Critics accused her of prioritizing health and agriculture interests and undermining Kennedy's agenda. Additionally, anti-abortion forces raised concerns about her stance on regulating the abortion pill mifepristone.
Overton's nomination was met with skepticism from Democrats and some Republicans, including Sen. Bill Cassidy, who expressed strong concerns about her role in the administration's plans to change childhood vaccine recommendations. The White House attempted to bolster her nomination on Monday by sharing a supportive statement from the former dean of the University of New Mexico School of Medicine.
Now, the HELP committee was set to vote on Overton's nomination on Wednesday, but with her nomination withdrawn, the Senate will need to find a new candidate to lead the FDA, currently overseen by acting Commissioner Kyle Diamantas.
Written by urgent.news from Axios's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.